Fingerpaint
Bill McEllen has been a leader in global biopharma commercialization for 30+ years. As Global President of Fingerpaint Group, he chairs the executive leadership team and oversees all of Fingerpaint’s business units. Under his leadership, the agency has experienced exponential growth, garnered 5 Agency of the Year awards in the last 5 years, and won a CLIO in a category alongside Nike and Budweiser. Prior to joining Fingerpaint, Bill spent 13 years with McCann Health as president of both McCann Torre Lazur and McCann Echo, where he led his agencies to 14 nominations as Agency of the Year in various industry publications.
Fingerpaint
3 followers
Fingerpaint, built on a foundation of empathy, at its core is committed to creating and executing meaningful brand experiences that are never paint by number for healthcare providers, care partners, and patients. In 2020, Fingerpaint acquired 1798, a market access and commercialization firm located in La Jolla, Calif., adding to its portfolio of services in support of biopharma customers. The agency also launched Photo 51, a gene therapy consultancy. Fingerpaint was named 2019 Agency of the Year by Med Ad News, and in 2018, it won the Heart Award from Med Ad News for its commitment to philanthropy and social causes. Additionally, it has been on Inc. Magazine’s list of the 5,000 Fastest-Growing Companies for the past eight years.